TFRC and cancer: The potentiation of Jaa’s activity, demonstratedby potent growth inhibitory, clonogenic and apoptosis assays, wasrelated to increased (and selective) recognition and uptake of AFt–JAaby TfR1, leading to enhanced accumulation of JAa within cancer cellswithout altering its mechanism of action.